These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 21901364)
1. Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4. Chen S; Liu AR; An FM; Yao WB; Gao XD Age (Dordr); 2012 Oct; 34(5):1211-24. PubMed ID: 21901364 [TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation. Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963 [TBL] [Abstract][Full Text] [Related]
3. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes. Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064 [TBL] [Abstract][Full Text] [Related]
5. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model. Gao C; Liu Y; Jiang Y; Ding J; Li L Brain Pathol; 2014 Apr; 24(3):261-9. PubMed ID: 24329968 [TBL] [Abstract][Full Text] [Related]
6. Effect of naringenin on brain insulin signaling and cognitive functions in ICV-STZ induced dementia model of rats. Yang W; Ma J; Liu Z; Lu Y; Hu B; Yu H Neurol Sci; 2014 May; 35(5):741-51. PubMed ID: 24337945 [TBL] [Abstract][Full Text] [Related]
7. Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway. Kang X; Wang D; Zhang L; Huang T; Liu S; Feng X; Guo Y; Zhang Z; Wang Z; Ren H; Yuan G Mol Med; 2023 Sep; 29(1):118. PubMed ID: 37667187 [TBL] [Abstract][Full Text] [Related]
8. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway. Akhtar A; Dhaliwal J; Saroj P; Uniyal A; Bishnoi M; Sah SP Inflammopharmacology; 2020 Apr; 28(2):385-400. PubMed ID: 31898080 [TBL] [Abstract][Full Text] [Related]
9. Exendin-4 Prevents Memory Loss and Neuronal Death in Rats with Sporadic Alzheimer-Like Disease. Zago AM; Carvalho FB; Rahmeier FL; Santin M; Guimarães GR; Gutierres JM; da C Fernandes M Mol Neurobiol; 2024 May; 61(5):2631-2652. PubMed ID: 37919602 [TBL] [Abstract][Full Text] [Related]
10. Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis. Liu P; Cui L; Liu B; Liu W; Hayashi T; Mizuno K; Hattori S; Ushiki-Kaku Y; Onodera S; Ikejima T Physiol Behav; 2020 Jan; 213():112689. PubMed ID: 31669775 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of 5-HT Afshar S; Shahidi S; Rohani AH; Soleimani Asl S; Komaki A J Chem Neuroanat; 2019 Mar; 96():140-147. PubMed ID: 30684605 [TBL] [Abstract][Full Text] [Related]
12. Dulaglutide ameliorates STZ induced AD-like impairment of learning and memory ability by modulating hyperphosphorylation of tau and NFs through GSK3β. Zhou M; Chen S; Peng P; Gu Z; Yu J; Zhao G; Deng Y Biochem Biophys Res Commun; 2019 Mar; 511(1):154-160. PubMed ID: 30773255 [TBL] [Abstract][Full Text] [Related]
13. GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease. Li Y; Duffy KB; Ottinger MA; Ray B; Bailey JA; Holloway HW; Tweedie D; Perry T; Mattson MP; Kapogiannis D; Sambamurti K; Lahiri DK; Greig NH J Alzheimers Dis; 2010; 19(4):1205-19. PubMed ID: 20308787 [TBL] [Abstract][Full Text] [Related]
14. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model. Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592 [TBL] [Abstract][Full Text] [Related]
15. Exendin-4 Improves Cognitive Function of Diabetic Mice via Increasing Brain Insulin Synthesis. Peng X; Shi X; Huang J; Zhang S; Yan Y; Ma D; Xu W; Xu W; Dong K; Tao J; Li M; Yang Y Curr Alzheimer Res; 2021; 18(7):546-557. PubMed ID: 34587885 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies. Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774 [TBL] [Abstract][Full Text] [Related]
17. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model. Shi L; Zhang Z; Li L; Hölscher C Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971 [TBL] [Abstract][Full Text] [Related]
18. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers. Bomfim TR; Forny-Germano L; Sathler LB; Brito-Moreira J; Houzel JC; Decker H; Silverman MA; Kazi H; Melo HM; McClean PL; Holscher C; Arnold SE; Talbot K; Klein WL; Munoz DP; Ferreira ST; De Felice FG J Clin Invest; 2012 Apr; 122(4):1339-53. PubMed ID: 22476196 [TBL] [Abstract][Full Text] [Related]
19. Streptozotocin produces oxidative stress, inflammation and decreases BDNF concentrations to induce apoptosis of RIN5F cells and type 2 diabetes mellitus in Wistar rats. Bathina S; Srinivas N; Das UN Biochem Biophys Res Commun; 2017 Apr; 486(2):406-413. PubMed ID: 28315336 [TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Tourrel C; Bailbé D; Meile MJ; Kergoat M; Portha B Diabetes; 2001 Jul; 50(7):1562-70. PubMed ID: 11423477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]